ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma

Table 1

Clinical data characteristic of 351 GC patients.

Items	Cases (total )	No. of events (%)	MST (days)	Crude	Crude HR (95% CI)
Age
≥60	239	108 (45.2)	766	0.017	Ref.
<60	106	35 (33.0%)	1811		0.629 (0.429-0.923)
Missing	6
Gender
Male	236	100 (42.4%)	869	0.184	Ref.
Female	125	44 (35.2%)	1043		0.787 (0.552-1.122)
Missing	0
Tumor stage
i	47	11 (23.4%)	2197	<0.001	0.260 (0.126-0.537)
ii	109	34 (31.2%)	1686		0.424 (0.247-0.728)
iii	147	69 (46.9%)	779		0.643 (0.397-1.042)
iv	35
Missing	13	22 (62.9%)	476		Ref.

Abbreviations: MST: median survival time; Ref.: reference; HR: hazard ratio; 95% CI: 95% confidence interval.